Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 51,000 shares at $11.93 ($597K) on 2006-11-09, disclosed to the SEC on 2006-11-09.
Open-market sale of $597k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.67 | 45,000 | $525K | 88.0% |
| 2 | $11.93 | 6,000 | $72K | 12.0% |
| Total | $11.70 avg | 51,000 | $597K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |